Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SYDTHY KLINIK FOR AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6%   Bankruptcy risk   0.7% 1.1% 1.0% 0.8% 0.9% 0.9% 10.0% 10.0%   Credit score (0-100)   94 84 86 90 90 88 25 25   Credit rating   AA A A A A A BB BB   Credit limit (kDKK)   150.9 53.4 109.1 175.9 163.2 202.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,606 1,456 1,403 1,423 1,265 1,303 0.0 0.0   EBITDA   601 462 665 789 555 711 0.0 0.0   EBIT   536 421 640 771 536 693 0.0 0.0   Pre-tax profit (PTP)   520.6 410.7 640.5 779.4 514.6 644.7 0.0 0.0   Net earnings   405.6 320.0 499.3 607.6 401.4 502.5 0.0 0.0   Pre-tax profit without non-rec. items   521 411 640 779 515 645 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   1,805 1,787 1,769 1,751 1,733 1,715 0.0 0.0   Shareholders equity total   1,133 1,203 1,453 1,610 1,662 2,164 1,639 1,639   Interest-bearing liabilities   2,711 2,615 2,572 2,307 2,384 2,280 0.0 0.0   Balance sheet total (assets)   4,402 4,350 4,473 4,394 4,421 4,880 1,639 1,639   Net Debt   2,708 2,612 2,569 2,304 2,381 2,277 -1,639 -1,639     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,606 1,456 1,403 1,423 1,265 1,303 0.0 0.0   Gross profit growth   1.5% -9.4% -3.6% 1.4% -11.1% 3.0% -100.0% 0.0%   Employees   2 2 2 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% -50.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,402 4,350 4,473 4,394 4,421 4,880 1,639 1,639   Balance sheet change%   -1.1% -1.2% 2.8% -1.8% 0.6% 10.4% -66.4% 0.0%   Added value   601.3 462.5 665.0 789.2 554.5 711.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -83 -59 -43 -36 -36 -36 -1,715 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.4% 28.9% 45.6% 54.2% 42.4% 53.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.2% 11.7% 16.6% 19.4% 14.2% 17.3% 0.0% 0.0%   ROI %   15.8% 13.1% 18.2% 21.2% 15.4% 18.6% 0.0% 0.0%   ROE %   38.4% 27.4% 37.6% 39.7% 24.5% 26.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   25.7% 27.7% 32.5% 36.6% 37.6% 44.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   450.4% 564.7% 386.3% 291.9% 429.4% 320.1% 0.0% 0.0%   Gearing %   239.2% 217.3% 177.1% 143.3% 143.5% 105.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 3.8% 3.5% 3.4% 4.8% 6.8% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 3.1 2.7 2.9 3.1 3.6 0.0 0.0   Current Ratio   0.2 3.1 2.7 2.9 3.1 3.6 0.0 0.0   Cash and cash equivalent   3.0 3.0 3.0 3.0 3.2 3.2 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -669.9 1,735.7 1,696.9 1,721.8 1,829.0 2,283.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   301 231 333 789 555 711 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   301 231 333 789 555 711 0 0   EBIT / employee   268 211 320 771 536 693 0 0   Net earnings / employee   203 160 250 608 401 502 0 0